141 related articles for article (PubMed ID: 21165581)
1. WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation.
Deng G; Li ZQ; Zhao C; Yuan Y; Niu CC; Zhao C; Pan J; Si WK
Oncol Rep; 2011 Feb; 25(2):367-76. PubMed ID: 21165581
[TBL] [Abstract][Full Text] [Related]
2. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
3. [Expression of wnt5a gene in hematologic diseases and leukemic cell lines].
Li ZQ; Si WK; Pan J; Yuan Y; Zou QM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):927-30. PubMed ID: 17956663
[TBL] [Abstract][Full Text] [Related]
4. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma.
Liu X; Wang Y; Wang X; Sun Z; Li L; Tao Q; Luo B
Arch Virol; 2013 Jan; 158(1):123-32. PubMed ID: 23001722
[TBL] [Abstract][Full Text] [Related]
6. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
Martín V; Valencia A; Agirre X; Cervera J; San Jose-Eneriz E; Vilas-Zornoza A; Rodriguez-Otero P; Sanz MA; Herrera C; Torres A; Prosper F; Román-Gómez J
Cancer Sci; 2010 Feb; 101(2):425-32. PubMed ID: 19874313
[TBL] [Abstract][Full Text] [Related]
8. [Expression level of miRNA-663 in different leukemic cell lines and its biological function].
Yang Y; Wang LL; Li YH; Gao XN; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):279-83. PubMed ID: 21518471
[TBL] [Abstract][Full Text] [Related]
9. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia.
Hatırnaz Ng Ö; Fırtına S; Can İ; Karakaş Z; Ağaoğlu L; Doğru Ö; Celkan T; Akçay A; Yıldırmak Y; Timur Ç; Özbek U; Sayitoğlu M
Turk J Haematol; 2015 Jun; 32(2):127-35. PubMed ID: 26316480
[TBL] [Abstract][Full Text] [Related]
10. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116.
Wang Z; Chen H
Anticancer Res; 2010 Nov; 30(11):4537-45. PubMed ID: 21115903
[TBL] [Abstract][Full Text] [Related]
11. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
12. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
[TBL] [Abstract][Full Text] [Related]
13. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
14. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
[TBL] [Abstract][Full Text] [Related]
15. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
Jin P; Song Y; Yu G
Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
17. miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Wei R; Deng Z; Su J
Biomed Pharmacother; 2015 May; 72():158-64. PubMed ID: 26054690
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
20. Promoter CpG methylation of oestrogen receptors in leukaemia.
Yao J; Huang Q; Zhang XB; Fu WL
Biosci Rep; 2009 Aug; 29(4):211-6. PubMed ID: 18808365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
